Cyanotech Corp. (NASDAQ:CYAN) belongs to Healthcare sector. Its net profit margin is -0.90% and weekly performance is -6.91%. On last trading day company shares ended up $8.89. Cyanotech Corp. (NASDAQ:CYAN) distance from 50-day simple moving average (SMA50) is -4.40%. Cyanotech Corporation (NASDAQ: CYAN) has experienced a delay in completing the necessary disclosures and finalizing its financial statements in connection with its Annual Report on Form 10-K for the year ended March 31, 2015 (the “Annual Report”). As a result of this delay, the Registrant was unable without unreasonable effort or expense to file its Annual Report by the prescribed filing date. The Company anticipates filing its Annual Report and related XBRL documents on or before the extended deadline of July 14, 2015.
Smith & Nephew plc (NYSE:SNN) shares increased 2.44% in last trading session and ended the day at $34.89. SNN Gross Margin is 75.60% and its return on assets is 7.00%. Smith & Nephew plc (NYSE:SNN) quarterly performance is 0.81%. Smith & Nephew plc (NYSE:SNN) announces the acquisition of the trauma and orthopaedics business of DeOst LLC and DC LLC, a manufacturing company in the DeOst group. DeOst has distributed Smith & Nephew’s products in Russia since 2009.
On 10 July, WSFS Financial Corp. (NASDAQ:WSFS) shares increased 0.86% and was closed at $28.13. WSFS EPS growth in last 5 year was 83.80%. WSFS Financial Corp. (NASDAQ:WSFS) year to date (YTD) performance is 10.19%. On 3 July, WSFS Financial Corporation, (NASDAQ:WSFS) announced the product introduction of WSFS Mobile Cash, a service that allows customers to securely withdraw cash from an ATM by using their WSFS Mobile Banking app. WSFS will be the fourth bank in the United States to offer the service.
The LGL Group, Inc. (NYSEMKT:LGL) ended the last trading day at $4.40. Company weekly volatility is calculated as 8.61% and price to cash ratio as 2.33. The LGL Group, Inc. (NYSEMKT:LGL) showed a weekly performance of 2.33%.
Alimera Sciences, Inc. (NASDAQ:ALIM) shares increased 3.40% in last trading session and ended the day at $4.56. ALIM Gross Margin is 88.30% and its return on assets is -53.40%. Alimera Sciences, Inc. (NASDAQ:ALIM) quarterly performance is -2.15%. Alimera Sciences (NASDAQ:ALIM) was upgraded by Zacks from a “hold” rating to a “buy” rating in a note issued to investors on Tuesday, MarketBeat reports. The firm currently has a $5.25 price objective on the biopharmaceutical company’s stock. Zacks‘s target price points to a potential upside of 15.64% from the company’s current price.